Replacement of rabbit pyrogen testing by an alternative test for plasma derived medicinal products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/BWP/452081/07
Published23/04/2009
Effective from01/11/2009
KeywordsPlasma derived medicinal products, rabbit pyrogen testing, bacterial endotoxin test, LAL test, monocyte activation test
DescriptionThis document lays down the requirements to be addressed in any justification for use of a test for bacterial endotoxins as an alternative to a test for pyrogens for plasma derived medicinal products. It specifically, addresses the LAL-testing related issues, process related considerations, clinical considerations and regulatory aspects to be considered when replacing the test for pyrogens by an alternative test.


Document history

First version

Current version

Adopted guideline


Overview of comments


Draft guideline

In operation: 01/11/2009–present


Published: 23/04/2009


Published: 05/12/2007


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more